StemGen, Inc.
SGNI · OTC
3/31/2022 | 12/31/2021 | 9/30/2021 | 6/30/2021 | |
|---|---|---|---|---|
| Market Cap | $114 | $114 | $69 | $45 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $115 | $115 | $69 | $46 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | – | -100% | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | – | 35.8% | – | 50% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | -136.7% | – | -372.4% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | -582.9% | – | -1,685.9% |
| EPS Diluted | -0.004 | -0.003 | -0.004 | -0.004 |
| % Growth | -69.2% | 29.7% | 0% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |